217 related articles for article (PubMed ID: 7855218)
1. Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists.
Ginski MJ; Witkin JM
Psychopharmacology (Berl); 1994 May; 114(4):573-82. PubMed ID: 7855218
[TBL] [Abstract][Full Text] [Related]
2. Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.
Geter-Douglass B; Witkin JM
Psychopharmacology (Berl); 1997 Sep; 133(1):43-50. PubMed ID: 9335079
[TBL] [Abstract][Full Text] [Related]
3. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
4. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
5. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
[TBL] [Abstract][Full Text] [Related]
6. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats.
Scalzo FM; Burge LJ
Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359
[TBL] [Abstract][Full Text] [Related]
7. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites.
Kamei H; Kameyama T; Nabeshima T
Eur J Pharmacol; 1996 Mar; 299(1-3):21-8. PubMed ID: 8901003
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan.
Zapata A; Gasior M; Geter-Douglass B; Tortella FC; Newman AH; Witkin JM
Pharmacol Biochem Behav; 2003 Jan; 74(2):313-23. PubMed ID: 12479950
[TBL] [Abstract][Full Text] [Related]
9. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Wlaź P
Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
[TBL] [Abstract][Full Text] [Related]
10. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.
Geter-Douglass B; Witkin JM
Psychopharmacology (Berl); 1999 Oct; 146(3):280-9. PubMed ID: 10541728
[TBL] [Abstract][Full Text] [Related]
11. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
Starr MS; Starr BS
Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
[TBL] [Abstract][Full Text] [Related]
13. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
DeLander GE; Wahl JJ
Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.
Koek W; Colpaert FC
J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
16. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
[TBL] [Abstract][Full Text] [Related]
17. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors.
Mori A; Noda Y; Mamiya T; Miyamoto Y; Nakajima A; Furukawa H; Nabeshima T
Behav Brain Res; 2001 Feb; 119(1):33-40. PubMed ID: 11164523
[TBL] [Abstract][Full Text] [Related]
19. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
Brent PJ
Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
[TBL] [Abstract][Full Text] [Related]
20. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
